Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
Ovaries01:26

Ovaries

The ovaries are roughly the size of almonds and measure approximately 2 to 3 centimeters in length. These paired structures are situated within the pelvic region and are anchored by the mesovarium—a peritoneal extension that also connects them to the wider structure of the broad ligament. The support system extends to the suspensory ligament, housing blood and lymphatic vessels. In addition, the ovarian ligament tethers the ovaries to the uterus.
On the ovarian surface, a layer of cuboidal...
Ovarian Cycle01:27

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Whole genome sequencing of pre-treatment and post-treatment locally advanced rectal cancer using long and short read technologies.

Scientific reports·2026
Same author

RETRACTED: Richards et al. Protein Tyrosine Phosphatase Non-Receptor 11 (<i>PTPN11</i>/Shp2) as a Driver Oncogene and a Novel Therapeutic Target in Non-Small Cell Lung Cancer (NSCLC). <i>Int. J. Mol. Sci.</i> 2023, <i>24</i>, 10545.

International journal of molecular sciences·2026
Same author

A pipeline of machine learning-driven multi-modal data fusion methods for prognostic risk analysis in bevacizumab-treated metastatic colorectal cancer.

Scientific reports·2026
Same author

Case Report: Whole-genome sequencing of urothelial carcinoma in an adult patient with CLOVES syndrome reveals a lack of <i>PIK3CA</i> mutation and a genomic landscape consistent with urothelial carcinoma.

Frontiers in oncology·2026
Same author

Early termination of NCT04617067, a phase II, open label, clinical trial of oral paricalcitol in combination with gemcitabine and NAB-paclitaxel therapy in advanced pancreatic cancer.

BMC cancer·2026
Same author

Dose Adjusted Neoadjuvant Paclitaxel, Carboplatin, Trastuzumab and Pertuzumab in Women With HER2 Positive Early Breast Cancer.

Clinical breast cancer·2025

相关实验视频

Updated: Jun 19, 2026

An Ex Vivo Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum
05:42

An Ex Vivo Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum

Published on: January 26, 2024

卵巢癌是发生在卵巢中的癌症.

Bryan T Hennessy1, Robert L Coleman, Maurie Markman

  • 1Department of Gynecologic Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Lancet (London, England)
|October 2, 2009
PubMed
概括

标准的上皮卵巢癌治疗包括手术和化疗. 虽然初始治疗是有效的,但复发是常见的,需要研究新型疗法,以改善患者的生存和结果.

科学领域:

  • 妇科瘤学 妇科瘤学
  • 医学瘤学 医学瘤学
  • 手术瘤学手术瘤学

背景情况:

  • 卵巢上皮癌 (EOC) 的管理通常包括手术分期,瘤解和化疗 (碳白/帕克利塔塞尔).
  • 最佳的手术解到<1厘米的残留疾病与更好的患者结局相关.
  • 大多数患者 (75%) 患有晚期疾病 (III/IV阶段),尽管初始应答率高于80%,但复发几乎是普遍的.

研究的目的:

  • 审查上皮卵巢癌的标准管理.
  • 突出突出瘤复发在晚期阶段的挑战.
  • 讨论潜在的未来治疗策略,以改善患者的治疗结果.

主要方法:

  • 对表皮卵巢癌的标准手术和化疗方案的审查.
  • 预后因素的分析,包括外科手术除的程度.
  • 探索新兴的治疗方式和药物输送技术.

主要成果:

  • 标准治疗提供了最初的好处,但通常会在15个月的中位数内出现瘤复发.
  • 二线治疗可以缓解症状并改善生活质量,但不能治愈.
  • 瘤复发仍然是晚期上皮卵巢癌的一个重大挑战.

更多相关视频

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
10:58

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

Transplantation Into the Mouse Ovarian Fat Pad
09:25

Transplantation Into the Mouse Ovarian Fat Pad

Published on: September 7, 2016

相关实验视频

Last Updated: Jun 19, 2026

An Ex Vivo Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum
05:42

An Ex Vivo Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum

Published on: January 26, 2024

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
10:58

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

Transplantation Into the Mouse Ovarian Fat Pad
09:25

Transplantation Into the Mouse Ovarian Fat Pad

Published on: September 7, 2016

结论:

  • 查,分子病原体理解,向疗法 (如贝瓦西祖马布) 和腹腔内药物输送方面的进展对于改善结果至关重要.
  • 未来的研究应该集中在克服治疗耐药性和预防复发的新型治疗策略上.
  • 通过结合早期检测和先进治疗方法的综合方法,预计在上皮卵巢癌中改善患者的治疗结果.